Skip to main content
Article thumbnail
Location of Repository

Perturbation of Interaction Networks for Application to Cancer Therapy

By Adrian P. Quayle, Asim S. Siddiqui and Steven J. M. Jones


We present a computational approach for studying the effect of potential drug combinations on the protein networks associated with tumor cells. The majority of therapeutics are designed to target single proteins, yet most diseased states are characterized by a combination of many interacting genes and proteins. Using the topology of protein-protein interaction networks, our methods can explicitly model the possible synergistic effect of targeting multiple proteins using drug combinations in different cancer types

Topics: Systems Biology Special Issue
Publisher: Libertas Academica
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2004). A census of human cancer genes.
  2. (2004). A fi rst-draft human protein-interaction map.
  3. (2002). An anatomy of normal and malignantgene expression.
  4. (2000). Approaches to detecting false positives in yeast two-hybrid systems.
  5. (2002). Assortative mixing in networks.
  6. (2002). Attack vulnerability of complex networks. Physical Review E,
  7. (2003). BIND: the biomolecular interaction network database.
  8. (1999). Biostatistical Analysis.
  9. (1998). Collective dynamics of small-world networks.
  10. (2003). Combinations of anticancer drugs and immunotherapy.
  11. (2005). Combining probability from independent test: The weighted Z method is superior to fi sher’s approach.
  12. (2002). Community structure in social and biological networks.
  13. (2004). Development of a cancer-targeted tissue specifi c promoter system.
  14. (2000). Developmental Biology. Sinauer Associates Inc.,
  15. (2002). DIP, the database of interacting proteins: a research tool for studying cellular networks of protein interactions.
  16. Emergence of scaling in random networks.
  17. (2000). Error and attack tolerance of complex networks.
  18. (2005). Functional cartography of complex metabolic networks.
  19. (1999). Gene expression profi ling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery.
  20. (2004). Genew: the human gene nomenclature database,
  21. (2004). Genomic analysis of essentiality within protein networks.
  22. (2002). Hierarchical organization of modularity in metabolic networks.
  23. (2005). High-betweenness proteins in the yeast protein interaction network.
  24. (2005). Inparanoid: a comprehensive database of eukaryotic orthologs.
  25. (2002). Integrating interactome, phenome, and transcriptome mapping data for the c. elegans germline.
  26. (2001). Is there a bias in proteome research?
  27. (2001). Lethality and centrality in protein networks.
  28. (2002). Metabolic network structure determines key aspects of functionality and regulation.
  29. (2004). Metabolics and systems biology: making sense of the soup.
  30. (2003). MicroSAGE is highly representative and reproducible but reveals major differences in gene expression among samples obtained from similar tissues.
  31. (2002). Modeling transcriptional regulatory networks.
  32. (2003). Modular organization of cellular networks.
  33. (1960). On the evolution of random graphs.
  34. (2003). Reconciling gene expression data with known genome-scale regulatory network structures.
  35. (2000). Resilience of the Internet to random breakdowns.
  36. (2005). SAGE: Current Technologies and Applications, chapter 1,
  37. (2000). SAGEmap: A public gene expression resource.
  38. (2003). Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents.
  39. (2001). Simultaneous modelling of metabolic, genetic and productinteraction networks.
  40. (1994). Social Network Analysis.
  41. (2005). The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what’s genetics got to do with it? Expert Opinion on Therapeutic Targets,
  42. (2000). The large-scale organisation of metabolic networks.
  43. (2005). The use of edgebetweenness clustering to investigate biological function in protein interaction networks.
  44. (2003). Topology of gene expression networks as revealed by data mining and modeling.
  45. (2002). TTD: Therapeutic target database.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.